Breaking News Instant updates and real-time market news.

XLRN

Acceleron

$46.24

-0.71 (-1.51%)

19:43
04/04/19
04/04
19:43
04/04/19
19:43

Acceleron ACE-2494 program was 'high-risk', says Piper Jaffray

Piper Jaffray analyst Danielle Brill keeps her Overweight rating and $74 price target on Acceleron after its discontinued Phase 1 safety trial of ACE-2494. The analyst says the program was already seen as " high-risk due to several failures with similar approaches" and it was not included in her valuation. The analyst keeps a positive view on the stock, expecting the company's Phase 2 myelofibrosis data to drive shares higher in the second half of 2019.

XLRN Acceleron
$46.24

-0.71 (-1.51%)

03/06/19
PIPR
03/06/19
NO CHANGE
PIPR
Departure of Gottlieb brings some biopharma uncertainty, says Piper Jaffray
Piper Jaffray remains "largely bullish" on the biopharma sector but acknowledges a "new and unexpected" source of uncertainty now with the announced departure of FDA commissioner Scott Gottlieb, analysts led by Christopher Raymond tell investors in a research note. With a track record of favoring innovation and pushing for increased regulatory efficiency while also advocating for more competition, Dr. Gottlieb was about as "market friendly, patient focused and industry friendly as one could have hoped," Piper writes. The firm adds that while it has no reason to believe the next commissioner "will be quite as radical and potentially damaging to the industry," it does think investors would do well to watch the selection process very closely.
02/26/19
02/26/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Acceleron (XLRN) initiated with an Outperform at Cowen. 2. Target (TGT) assumed with a Neutral at Citi. 3. Capri Holdings (CPRI) reinstated with an Overweight. 4. Starwood Property (STWD) initiated with a Buy at BTIG. 5. Essential Properties Realty Trust (EPRT) initiated with a Market Perform at Raymond James. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/26/19
HCWC
02/26/19
NO CHANGE
Target $72
HCWC
Buy
H.C. Wainwright keeps Buy rating on Acceleron after updated luspatercept timing
After Acceleron's (XLRN) partner, Celgene (CELG), announced updated timing for the anticipated submission of a Biologics License Application with the U.S. FDA for luspatercept, H.C. Wainwright analyst Edward White noted that the BLA is now seen being submitted in April 2019, versus prior guidance for the first half of 2019. He expects the drug to be launched in early 2020 and his expectations remain at $32.5M in 2020 sales for beta-thalassemia and $131.3M in 2020 sales for myelodysplastic syndromes, or MDS. White keeps a Buy rating and $72 price target on Acceleron shares.
02/25/19
COWN
02/25/19
INITIATION
Target $78
COWN
Outperform
Cowen starts Acceleron with Outperform rating, calls it top mid-cap pick
Cowen analyst Yaron Werber initiated Acceleron with an Outperform rating and $78 price target, stating that he anticipates filing in H1:19 and approval in H1:20 for luspatercept for transfusion-dependent beta-thalassemia and that his consultants expect "rapid uptake." He also has "high conviction" that the ongoing phase 3 COMMANDS study in first-line myelodysplastic syndromes in H1:21 and the phase 2 BEYOND study for non-transfusion dependent beta-thal will be positive, said Werber, who called Acceleron his top mid-cap pick.

TODAY'S FREE FLY STORIES

07:45
04/25/19
04/25
07:45
04/25/19
07:45
General news
Treasury Market Outlook: bond markets are mixed »

Treasury Market Outlook:…

XLNX

Xilinx

$139.79

2.66 (1.94%)

07:44
04/25/19
04/25
07:44
04/25/19
07:44
Downgrade
Xilinx rating change  »

Xilinx downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

CIGI

Colliers International

$69.14

-0.39 (-0.56%)

07:44
04/25/19
04/25
07:44
04/25/19
07:44
Hot Stocks
Colliers International acquires affiliate in Sweden »

Colliers International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 05

    Jun

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:43
04/25/19
04/25
07:43
04/25/19
07:43
Earnings
AbbVie raises FY19 adj. EPS view to $8.73-$8.83 from $8.65-$8.75 »

FY19 consensus $8.69. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

HAS

Hasbro

$103.18

2.84 (2.83%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Downgrade
Hasbro rating change  »

Hasbro downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 29

    May

WAB

Wabtec

$76.57

-0.19 (-0.25%)

, GE

General Electric

$9.32

-0.025 (-0.27%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Hot Stocks
Wabtec CEO Ray Betler to retire, Rafael Santana to succeed »

Wabtec (WAB) announced…

WAB

Wabtec

$76.57

-0.19 (-0.25%)

GE

General Electric

$9.32

-0.025 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 08

    May

  • 08

    May

  • 21

    May

  • 29

    May

  • 05

    Jun

  • 05

    Jun

  • 13

    Nov

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Hot Stocks
Breaking Hot Stocks news story on AbbVie »

AbbVie raises FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Earnings
AbbVie reports Q1 adjusted EPS $2.14, consensus $2.06 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

HBAN

Huntington Bancshares

$13.75

-0.04 (-0.29%)

07:40
04/25/19
04/25
07:40
04/25/19
07:40
Earnings
Huntington Bancshares sees FY19 revenue up 4%-7%, consensus $4.76B »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

  • 31

    May

  • 29

    Aug

REPL

Replimune Group

$15.32

1 (6.98%)

07:40
04/25/19
04/25
07:40
04/25/19
07:40
Initiation
Replimune Group initiated  »

Replimune Group added to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALKS

Alkermes

$34.80

0.6 (1.75%)

07:40
04/25/19
04/25
07:40
04/25/19
07:40
Hot Stocks
Alkermes reports Q1 Vivitrol revenue $69.2M vs. $62.7M last year »

Reports Q1 Aristada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

FCN

FTI Consulting

$78.95

-0.04 (-0.05%)

07:40
04/25/19
04/25
07:40
04/25/19
07:40
Earnings
FTI Consulting backs FY19 adj. EPS view $3.50-$4.00, consensus $3.71 »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 29

    Apr

RRC

Range Resources

$9.76

0.08 (0.83%)

07:39
04/25/19
04/25
07:39
04/25/19
07:39
Downgrade
Range Resources rating change  »

Range Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 22

    May

SWK

Stanley Black & Decker

$145.79

-1.58 (-1.07%)

07:38
04/25/19
04/25
07:38
04/25/19
07:38
Recommendations
Stanley Black & Decker analyst commentary  »

Stanley Black &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 16

    May

FCN

FTI Consulting

$78.95

-0.04 (-0.05%)

07:37
04/25/19
04/25
07:37
04/25/19
07:37
Earnings
FTI Consulting reports Q1 adj. EPS $1.63, consensus 99c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 29

    Apr

NCI

Navigant Consulting

$21.00

0.38 (1.84%)

07:37
04/25/19
04/25
07:37
04/25/19
07:37
Earnings
Navigant Consulting backs FY19 adjusted EPS view 85c-$1.00, consensus 89c »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

  • 23

    May

  • 28

    May

SAH

Sonic Automotive

$15.84

0.45 (2.92%)

07:36
04/25/19
04/25
07:36
04/25/19
07:36
Earnings
Sonic Automotive reports Q1 adjusted EPS 39c, consensus 23c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 13

    Nov

TSLA

Tesla

$258.70

-5.15 (-1.95%)

07:36
04/25/19
04/25
07:36
04/25/19
07:36
Recommendations
Tesla analyst commentary  »

Tesla seems less opposed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BWB

Bridgewater Bancshares

$10.53

-0.07 (-0.66%)

07:36
04/25/19
04/25
07:36
04/25/19
07:36
Earnings
Bridgewater Bancshares reports Q1 EPS 23c, consensus 24c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$182.64

-1.13 (-0.61%)

07:36
04/25/19
04/25
07:36
04/25/19
07:36
Recommendations
Facebook analyst commentary at Morgan Stanley »

Facebook price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 03

    Jun

NCI

Navigant Consulting

$21.00

0.38 (1.84%)

07:35
04/25/19
04/25
07:35
04/25/19
07:35
Hot Stocks
Navigant Consulting CEO says 'poised to deliver' 2019 cont ops. guidance targets »

CEO Julie Howard said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

  • 23

    May

  • 28

    May

NOW

ServiceNow

$242.41

-1.085 (-0.45%)

07:35
04/25/19
04/25
07:35
04/25/19
07:35
Recommendations
ServiceNow analyst commentary  »

ServiceNow price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    May

WAB

Wabtec

$76.57

-0.19 (-0.25%)

07:35
04/25/19
04/25
07:35
04/25/19
07:35
Earnings
Wabtec backs FY19 adj. EPS view $4.00-$4.20, consensus $4.15 »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

  • 21

    May

  • 05

    Jun

  • 13

    Nov

FB

Facebook

$182.64

-1.13 (-0.61%)

, CVE

Cenovus Energy

$10.19

-0.25 (-2.39%)

07:35
04/25/19
04/25
07:35
04/25/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

FB

Facebook

$182.64

-1.13 (-0.61%)

CVE

Cenovus Energy

$10.19

-0.25 (-2.39%)

AMRN

Amarin

$18.47

0.08 (0.44%)

ORCL

Oracle

$55.17

0.23 (0.42%)

OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

COP

ConocoPhillips

$64.71

-1.74 (-2.62%)

JNPR

Juniper

$28.73

0.355 (1.25%)

IVZ

Invesco

$21.53

-0.09 (-0.42%)

CSIQ

Canadian Solar

$20.17

-0.085 (-0.42%)

CNSL

Consolidated Communications

$8.89

-0.03 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 28

    Apr

  • 29

    Apr

  • 30

    Apr

  • 01

    May

  • 06

    May

  • 07

    May

  • 08

    May

  • 10

    May

  • 14

    May

  • 14

    May

  • 22

    May

  • 29

    May

  • 30

    May

  • 03

    Jun

NCI

Navigant Consulting

$21.00

0.38 (1.84%)

07:34
04/25/19
04/25
07:34
04/25/19
07:34
Earnings
Navigant Consulting reports Q1 adjusted EPS 18c, consensus 8c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

  • 23

    May

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.